Please enable JavaScript.
Coggle requires JavaScript to display documents.
Poisoned cough syrup traced to India reveals lapses in regulation. -…
Poisoned cough syrup traced to India reveals lapses in regulation.
Sub Claim
A tragic outbreak in Gambia linked to defective Indian cough syrups led to the loss of numerous young lives.
Regulatory issues in India's pharmaceutical industry: Insufficient inspections, limited cooperation between national and local regulators.
Logic for Sub-Claims
The Gambia outbreak underscores harm and deaths caused by contaminated Indian cough syrups abroad.
regulatory oversight and resource concerns as evidence of inadequate oversight in India's pharmaceutical industry.
India's major role in global pharmaceuticals due to its significant export of generic drugs.
multiple cases of contaminated drugs tied to India to illustrate issues in the Indian pharmaceutical industry.
The generic medicine supply chain heavily depends on the rapidly growing Indian pharmaceutical industry.
Indian pharmaceutical industry: Repeated contamination issues causing harm locally and internationally.
Central Claim
contaminated drugs have caused harm and even fatalities, affecting not only people in India but also those in other countries.
Logic for Central Claim
Sub Claim
Instances of contaminated drugs.
Inadequate regulations.
India's significant role in global pharmaceutical industry.
Complex supply chains.
Logic
Indian pharmaceutical industry is affected a lot.
Everything occurred results in drug contamination and consequences.
Central Claim
2.Instances of contaminated drugs.
3.Regulatory inadequacies.
1.India's significant global pharmaceutical role.
4.Complex supply chains causing harm domestically and internationally.
lax regulation, convoluted supply chains, and a profit-driven mindset in the Indian pharmaceutical industry have led to the production and distribution of contaminated drugs.
Facts/Evidence
In India's pharmaceutical sector: Coordination gaps between regulators, inadequate inspection resources.
Indian firm, Maiden Pharmaceuticals Ltd., linked to over 60 child death in Gambia due to tainted cough syrups.
Reports of tainted Indian pharmaceuticals causing harm abroad.
India is a big supplier of generic drugs to the global pharmaceutical market.